CMS Signals Continued Aggressive Expansion Of The ASC Covered Procedures List

Published On: February 3, 2026Categories: Business

CMS entered January with momentum already firmly established, and internal signals throughout the month continued to confirm what many operators have suspected for years: the agency increasingly views outpatient surgery expansion as not only clinically defensible, but fiscally unavoidable. Since 2018, the ASC Covered Procedures List has expanded from approximately 3,200 approved procedures to more than 5,200, representing a net increase of over 60%. What is particularly telling is not just the growth itself, but its pace. More than 40% of those additions occurred in the past three years alone, reflecting clear acceleration rather than slow, linear expansion.

Internal CMS analyses circulated quietly in early January reinforced that, for carefully selected orthopedic, general surgery, ENT, urology, and vascular procedures, ASC complication rates, readmission rates, and unplanned transfer rates now meet—or in many cases outperform—hospital outpatient department benchmarks. These results were not accidental. They were driven by improved anesthesia protocols, narrower and more disciplined patient selection criteria, shorter operative times, and enhanced recovery pathways that materially reduce post-anesthesia risk windows.

By late January, CMS policy staff were openly discussing—both internally and in limited external forums—that 25–30% of procedures still labeled “inpatient-only” could be clinically reclassified over the next five to seven years. Internal modeling repeatedly referenced advances in minimally invasive surgical techniques, ultrasound-guided regional anesthesia, lower-dose multimodal analgesia, and increasingly standardized same-day discharge protocols as primary drivers of this shift.

For individual centers, the financial implications are neither abstract nor theoretical. Adding even 10–15 higher-acuity CPT codes—with average Medicare facility payments ranging from $4,000 to $18,000 per case and commercial payments often running 20–60% higher—can realistically generate between $750,000 and $2.5 million in incremental annual facility revenue. Importantly, this revenue is often achieved without expanding physical footprint, increasing fixed overhead, or materially altering staffing ratios. As a result, it represents one of the highest-margin growth vectors currently available to ASC operators willing to execute carefully.